Sunmax Biotechnology Co., Ltd. (TPEX:4728)
419.00
+11.00 (2.70%)
May 23, 2025, 1:30 PM CST
Sunmax Biotechnology Revenue
Sunmax Biotechnology had revenue of 554.17M TWD in the quarter ending March 31, 2025, with 29.59% growth. This brings the company's revenue in the last twelve months to 1.94B, up 12.82% year-over-year. In the year 2024, Sunmax Biotechnology had annual revenue of 1.82B with 7.64% growth.
Revenue (ttm)
1.94B
Revenue Growth
+12.82%
P/S Ratio
11.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
22.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.82B | 129.03M | 7.64% |
Dec 31, 2023 | 1.69B | 288.91M | 20.64% |
Dec 31, 2022 | 1.40B | 364.42M | 35.19% |
Dec 31, 2021 | 1.04B | 179.81M | 21.01% |
Dec 31, 2020 | 855.85M | 261.71M | 44.05% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Oneness Biotech | 117.33M |
Center Laboratories | 1.63B |
Lumosa Therapeutics | 43.59M |